dyslipidemia
DYSLIPIDEMIA
Dyslipidemia is having an abnormal amount of lipids or fats in the blood.
Lipid profile is obtained from an individual with diabetes mellitus, coronary heart disease, cerebrovascular disease, peripheral arterial disease or other coronary heart disease risk factors or from an individual with family history or clinical evidence of familial hypercholesterolemia.
Plasma lipids are total cholesterol, high-density lipoprotein cholesterol, trigylcerides, and low-density lipoprotein cholesterol.
Evaluation of lipid profile must be performed in parallel with the risk assessment of coronary heart disease.
Drug Information
Atozet
atorvastatin + ezetimibe

Indication: Reduced risk of CV death, nonfatal MI & stroke, hospitalization for unstable angina or need for revascular...

Indication: Reduction of elevated total cholesterol (total-C), LDL-C, ApoB, total-C: HDL-C ratio, triglycerides & incr...

Indication: Adjunct to diet & other non-pharmacological treatment for severe hypertriglyceridaemia w/ or w/o low HDL c...

Indication: Primary hypercholesterolaemia: Administered alone or w/ an HMG-CoA reductase inhibitor (statin) indicated as a...

Indication: Adjunct to diet for patients w/ elevated total cholesterol (total-C) & LDL-cholesterol (LDL-C), apolipopro...

Indication: Primary hypercholesterolemia: Adjunctive therapy to diet for the reduction of elevated total cholesterol (tota...

Indication: Adjunct to diet for patients w/ elevated total cholesterol, LDL-cholesterol, apolipoprotein B & triglyceri...

Indication: Hyperlipidaemia.

Indication: Patients for whom treatment w/ both amlodipine & atorvastatin is appropriate: Amlodipine component 1st-lin...

Indication: Hypercholesterolaemia & hypertriglyceridaemia alone or combined (types IIa, IIb, III, IV, V dyslipidaemias...

1  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
23 Mar 2020
Heart failure (HF) is a progressive condition where the heart is unable to pump enough blood to meet the body’s needs. Common causes of HF include ischaemic heart disease (IHD), hypertension, cardiomyopathy, diabetes and thyroid disorders. Patients with HF generally require lifelong treatment, but often ask if their medications may be stopped once their symptoms have improved. In this case study, Dato’ Dr Azmee Mohd Ghazi shares his clinical experience treating HF and the current evidence for HF therapy withdrawal.
09 Feb 2020
Hyponatraemia during admission for acute decompensated heart failure (ADHF) necessitates higher doses of the diuretic furosemide, reports a recent study.